Literature DB >> 7822069

Differential expression of interleukin-2 receptor alpha and beta chains in relation to natural killer cell subsets and aerobic fitness.

S G Rhind1, P N Shek, S Shinkai, R J Shephard.   

Abstract

Immunophenotyping by dual parameter flow cytometry was used to compare the expression of interleukin-2 receptor alpha and beta chains on lymphocyte subsets in the peripheral blood of 7 trained and 6 untrained volunteers (respective VO2max 57.0 +/- 6.1 and 39.0 +/- 4.5 ml.kg-1.min-1). Venous blood samples were collected at least 36 h after the most recent exercise session. The trained subjects had higher circulating counts (10(9).l-1) of total leukocytes (5.80 +/- 0.83 vs. 4.63 +/- 0.21, p < 0.05), granulocytes (3.14 +/- 0.72 vs. 1.90 +/- 0.30, p < 0.05), and NK cells (CD16+, 0.32 +/- 0.14 vs. 0.16 +/- 0.05, p < 0.05; CD56+, 0.41 +/- 0.14 vs. 0.21 +/- 0.03, p < 0.01), but lower lymphocyte counts than their sedentary peers (1.90 +/- 0.22 vs. 2.26 +/- 0.25, p < 0.05). Counts for T cells (CD3+) and B cells (CD19+), and the CD4+/CD8+ ratio did not differ between the two subject groups. The p55-IL-2 receptor alpha expression (CD25+: 0.63 +/- 0.11 vs. 0.69 +/- 0.17) was unrelated to training, but the p70-75-IL-2 receptor beta expression was higher in the active group (p70/Mik-beta 1+: 0.42 +/- 0.09 vs. 0.20 +/- 0.06, p < 0.001; p75/TU27+: 0.36 +/- 0.08 vs. 0.17 +/- 0.07, p < 0.005). Beta chain co-expression was also higher on NK cell subsets (p < 0.001) in trained than in sedentary subjects. Aerobic power was strongly correlated with IL-2R beta expression (r = 0.914, p < 0.001 for Mik-beta 1; r = 0.884, p < 0.005 for TU27).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822069     DOI: 10.1055/s-2007-1021066

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  11 in total

1.  Effects of exercise and training on natural killer cell counts and cytolytic activity: a meta-analysis.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1999-09       Impact factor: 11.136

Review 2.  Lymphocyte responses to maximal exercise: a physiological perspective.

Authors:  Henning Bay Nielsen
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Effects of heat and intermittent exercise on leukocyte and sub-population cell counts.

Authors:  Y Severs; I Brenner; P N Shek; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

4.  The effects of incremental submaximal exercise on circulating leukocytes in physically active and sedentary males and females.

Authors:  N M Moyna; G R Acker; K M Weber; J R Fulton; F L Goss; R J Robertson; B S Rabin
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 5.  Flow cytometry. Principles and applications in exercise immunology.

Authors:  H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-11       Impact factor: 11.136

6.  Effects of moderate endurance exercise and training on in vitro lymphocyte proliferation, interleukin-2 (IL-2) production, and IL-2 receptor expression.

Authors:  S G Rhind; P N Shek; S Shinkai; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 7.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

8.  Aerobic training increases the stimulated percentage of CD4+CD25+ in older men but not older women.

Authors:  Suzanne Broadbent; Gregory Gass
Journal:  Eur J Appl Physiol       Date:  2008-01-19       Impact factor: 3.078

Review 9.  Associations between physical activity and susceptibility to cancer: possible mechanisms.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1998-11       Impact factor: 11.136

Review 10.  The cytokine response to physical activity and training.

Authors:  A I Moldoveanu; R J Shephard; P N Shek
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.